IT
Intelligent Therapeutics, Inc.
SEC filingOther Technology · Eugene, OR
Amount raised$100Ksold at filing
Total offering$700K$600K still open
Investors in the raise2count reported to the SEC
FiledMay 28, 2026first sale May 13, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Nathan BernsteinExecutive Officer, Director
Jason GallicExecutive Officer, Director
David ShearDirector
Thomas EmmonsExecutive Officer, Director
Michael ZvolenskyExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.